Literature DB >> 32243726

Racial differences in HPV type 16 prevalence in women with ASCUS of the uterine cervix.

Carolann Risley1,2, Megan A Clarke2, Kim R Geisinger1, Mary W Stewart1, Lei Zhang1,3, Kim W Hoover1, Laree M Hiser1, Kenyata Owens1,4, Maria DeMarco2, Mark Schiffman2, Nicolas Wentzensen2.   

Abstract

BACKGROUND: Understanding racial influences on human papillomavirus (HPV) distribution in women with atypical squamous cells of undetermined significance (ASCUS) cytology via partial genotyping in a statewide population can inform HPV-based prevention efforts.
METHODS: Women aged 21 to 65 years with any cytology result and partial HPV genotyping for ASCUS triage between January 1, 2014, and December 31, 2017, were included. All women attended a Mississippi State Department of Health clinic. Age, race, cytopathologic, and HPV data were extracted from the electronic health record and analyzed. Cytologic specimens were processed with ThinPrep and HPV testing with the Cobas 4800 assay. HPV genotypes were evaluated in hierarchical categories. Chi-square tests and multinomial logistic regression models evaluated associations between race and type prevalence.
RESULTS: There were 43,106 women who underwent cervical cancer screening with cytology and ASCUS triage. Of these, 34,363 (80.2%) had normal cytology, 4672 (10.9%) had ASCUS, 2683 (6.3%) had a low-grade squamous intraepithelial lesion, and 633 (1.5%) had a high-grade squamous intraepithelial lesion. Blacks represented 69.3% of the sample and had a higher proportion of HPV-positive ASCUS (6.5%) in comparison with whites (5.6%). Blacks had significantly decreased odds of HPV-16 (odds ratio [OR], 0.66; 95% confidence interval [CI], 0.6-0.9; P = .002) and significantly increased odds for 12 other types (OR, 1.37; 95% CI, 1.2-1.5; P < .0001) in comparison with whites.
CONCLUSIONS: In a diverse population, significant differences in HPV genotypes are shown by race. Importantly, blacks with ASCUS are less likely to be positive for HPV-16 in comparison with whites. Ongoing work is evaluating the individual genotype prevalence and genotype-specific risk of precancer by race.
© 2020 American Cancer Society.

Entities:  

Keywords:  atypical squamous cells of undetermined significance; cervical cancer; cervical cancer screening; human papillomavirus (HPV); human papillomavirus genotypes

Mesh:

Year:  2020        PMID: 32243726      PMCID: PMC7728239          DOI: 10.1002/cncy.22267

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  18 in total

1.  Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.

Authors:  Julia C Gage; William C Hunt; Mark Schiffman; Hormuzd A Katki; Li A Cheung; Orrin Myers; Jack Cuzick; Nicolas Wentzensen; Walter Kinney; Philip E Castle; Cosette M Wheeler
Journal:  Obstet Gynecol       Date:  2016-12       Impact factor: 7.661

2.  Human papillomavirus type 16 and 18 variants: race-related distribution and persistence.

Authors:  Long Fu Xi; Nancy B Kiviat; Allan Hildesheim; Denise A Galloway; Cosette M Wheeler; Jesse Ho; Laura A Koutsky
Journal:  J Natl Cancer Inst       Date:  2006-08-02       Impact factor: 13.506

3.  The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.

Authors:  Mark Schiffman; Sean Boyle; Tina Raine-Bennett; Hormuzd A Katki; Julia C Gage; Nicolas Wentzensen; Janet R Kornegay; Raymond Apple; Carrie Aldrich; Henry A Erlich; Thanh Tam; Brian Befano; Robert D Burk; Philip E Castle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-18       Impact factor: 4.254

4.  Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.

Authors:  Peng Guan; Rebecca Howell-Jones; Ni Li; Laia Bruni; Silvia de Sanjosé; Silvia Franceschi; Gary M Clifford
Journal:  Int J Cancer       Date:  2012-03-20       Impact factor: 7.396

5.  A cohort study of cervical screening using partial HPV typing and cytology triage.

Authors:  Mark Schiffman; Noorie Hyun; Tina R Raine-Bennett; Hormuzd Katki; Barbara Fetterman; Julia C Gage; Li C Cheung; Brian Befano; Nancy Poitras; Thomas Lorey; Philip E Castle; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2016-08-26       Impact factor: 7.396

Review 6.  Triage of HPV positive women in cervical cancer screening.

Authors:  Nicolas Wentzensen; Mark Schiffman; Timothy Palmer; Marc Arbyn
Journal:  J Clin Virol       Date:  2015-11-28       Impact factor: 3.168

Review 7.  The natural history of human papillomavirus infection.

Authors:  Silvia de Sanjosé; Maria Brotons; Miguel Angel Pavón
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2017-09-06       Impact factor: 5.237

Review 8.  Carcinogenic human papillomavirus infection.

Authors:  Mark Schiffman; John Doorbar; Nicolas Wentzensen; Silvia de Sanjosé; Carole Fakhry; Bradley J Monk; Margaret A Stanley; Silvia Franceschi
Journal:  Nat Rev Dis Primers       Date:  2016-12-01       Impact factor: 52.329

9.  HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.

Authors:  Susan Hariri; Martin Steinau; Allen Rinas; Julia W Gargano; Christina Ludema; Elizabeth R Unger; Alicia L Carter; Kathy L Grant; Melanie Bamberg; James E McDermott; Lauri E Markowitz; Noel T Brewer; Jennifer S Smith
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

10.  Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population: Results of the Becton Dickinson Onclarity Trial.

Authors:  Thomas C Wright; Mark H Stoler; Valentin Parvu; Karen Yanson; Karen Eckert; Salma Kodsi; Charles K Cooper
Journal:  Am J Clin Pathol       Date:  2019-01-01       Impact factor: 2.493

View more
  5 in total

1.  Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.

Authors:  Jacqueline Mix; Mona Saraiya; Benjamin D Hallowell; Brian Befano; Li C Cheung; Elizabeth R Unger; Julia W Gargano; Lauri E Markowitz; Philip E Castle; Tina Raine-Bennett; Joan Walker; Rosemary Zuna; Mark Schiffman; Nicolas Wentzensen; Julia C Gage
Journal:  J Natl Cancer Inst       Date:  2022-06-13       Impact factor: 11.816

2.  The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China.

Authors:  Diling Pan; Binhua Dong; Hangjing Gao; Xiaodan Mao; Huifeng Xue; Pengming Sun
Journal:  Risk Manag Healthc Policy       Date:  2020-09-24

3.  HPV E1 qPCR, a Low-Cost Alternative Assay to Roche Diagnostic Linear Array is Effective in Identifying Women at Risk for Developing Cervical Cancer.

Authors:  Chandrika J Piyathilake; Suguna Badiga; Janice L Simons; Walter C Bell; Pauline E Jolly
Journal:  Int J Womens Health       Date:  2022-02-19

4.  ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cells of undetermined significance: a diagnostic test.

Authors:  Ling Wang; Qingxia Song; Ying Liu; Qiang Ou
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

5.  STRIDES - STudying Risk to Improve DisparitiES in Cervical Cancer in Mississippi - Design and baseline results of a Statewide Cohort Study.

Authors:  Carolann Risley; Mary W Stewart; Kim R Geisinger; Laree M Hiser; Jody C Morgan; Kenyata J Owens; Krishna Ayyalasomayajula; Rhonda M Rives; Ashish Jannela; Dianne E Grunes; Lei Zhang; Mark Schiffman; Nicolas Wentzensen; Megan A Clarke
Journal:  Prev Med       Date:  2021-07-20       Impact factor: 4.018

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.